THEODORE WENSEL to Genetic Therapy
This is a "connection" page, showing publications THEODORE WENSEL has written about Genetic Therapy.
Connection Strength
0.348
-
Rhodopsin-EGFP knock-ins for imaging quantal gene alterations. Vision Res. 2005 Dec; 45(28):3445-53.
Score: 0.146
-
The nature of dominant mutations of rhodopsin and implications for gene therapy. Mol Neurobiol. 2003 Oct; 28(2):149-58.
Score: 0.128
-
Knock-in human rhodopsin-GFP fusions as mouse models for human disease and targets for gene therapy. Proc Natl Acad Sci U S A. 2004 Jun 15; 101(24):9109-14.
Score: 0.033
-
Blocking transcription of the human rhodopsin gene by triplex-mediated DNA photocrosslinking. Nucleic Acids Res. 2000 Nov 01; 28(21):4283-90.
Score: 0.026
-
Rhodopsin gene expression determines rod outer segment size and rod cell resistance to a dominant-negative neurodegeneration mutant. PLoS One. 2012; 7(11):e49889.
Score: 0.015